Autoinjectors Market Size- By Application, By Type, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Description

Autoinjectors Market Introduction and Overview

According to SPER market research, 'Autoinjectors Market Size - By Application, By Type, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2033' state that the Global Autoinjectors Market is predicted to reach USD 41.82 billion by 2033 with CAGR of 16.34%.

One dose of medication, mostly life-saving medications, is administered via autoinjectors. The main purpose of these spring-loaded autoinjectors is to apply drugs in a secure and safe manner. The auto-injector delivery system has revolutionized the industry and changed people's perceptions. Human growth hormones are administered using self-injectors; insulin was recently supplanted by highly developed autoinjectors. Spring-loaded, single-use, disposable syringes (prefilled syringes) are the most common type of autoinjector.

There has been a noticeable decrease in patients postponing seeking therapy and treatment once the limits were changed. The market for autoinjectors has benefited from COVID-19. Self-injections have become increasingly popular as a result of the COVID-19 pandemic, giving patients greater involvement and control over their care. The market for autoinjectors has seen a resurgence of advanced technologies because they enable improved injection speed and the management of treatment anxiety.

Scope of the Report:

Report Metric Details

Market size available for years 2020-2033

Base year considered 2023

Forecast period 2024-2033

Segments covered By Application, By Type, By End User

Regions covered North America, Europe, Asia - Pacific, Middle East, and Africa, and South America

Companies Covered Abbie, Amgen, AstraZeneca, Bayer, Becton, Dickinson and Company, Biogen, Eli Lilly, Novartis, Teva Pharmaceuticals, and Ypsomed and various others.

Global Autoinjectors Market Segmentation:

By Application: Based on the Application, Global Autoinjectors Market is segmented as; Rheumatoid Arthritis, Multiple Sclerosis, Anaphylaxis, and Others.

By Type: Based on the Type, Global Autoinjectors Market is segmented as; Disposable Autoinjectors and Reusable Autoinjectors.

By End-User: Based on the End-User, Global Autoinjectors Market is segmented as; Home Care Settings, Hospital and Clinics, and Others.

Product Code: MEDE2412

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPER's internal database
- 2.1.4. Premium insight from KOL's
2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges
4.2. COVID-19 Impact of the Global Autoinjectors Market

5. Market variable and outlook

5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
5.3. PORTER's Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
5.4. Heat Map Analysis

6. Competitive Landscape

6.1. Global Autoinjectors Market Manufacturing Base Distribution, Sales Area, Type, Application
6.2. Mergers & Acquisitions, Partnerships, Type Launch, and Collaboration in Global Autoinjectors Market

7. Global Autoinjectors Market, By Application, 2020-2033 (USD Million)

7.1. Global Autoinjectors Market Value Share and Forecast, By Application, 2024-2033
7.2. Anaphylaxis
7.3. Multiple Sclerosis
7.4. Rheumatoid Arthritis
7.5. Others

8. Global Autoinjectors Market, By Type, 2020-2033 (USD Million)

8.1. Global Autoinjectors Market Value Share and Forecast, By Type, 2024-2033
8.2. Disposable Autoinjectors
8.3. Reusable Autoinjectors

9. Global Autoinjectors Market, By End User, 2020-2033 (USD Million)

9.1. Global Autoinjectors Market Value Share and Forecast, By Type, 2024-2033
9.2. Home Care Settings
9.3. Hospital and Clinics
9.4. Others

10. Global Autoinjectors Market Forecast, 2020-2033 (USD Million)

10.1. Global Autoinjectors Market Size and Market Share

11. Global Autoinjectors Market, By Application, 2020-2033 (USD Million)

11.1. Global Autoinjectors Market Size and Market Share By Application (2020-2026)
11.2. Global Autoinjectors Market Size and Market Share By Application (2027-2033)

12. Global Autoinjectors Market, By Type, 2020-2033 (USD Million)

12.1. Global Autoinjectors Market Size and Market Share By Type (2020-2026)
12.2. Global Autoinjectors Market Size and Market Share By Type (2027-2033)

13. Global Autoinjectors Market, By End User, 2020-2033 (USD Million)

13.1. Global Autoinjectors Market Size and Market Share By End User (2020-2026)
13.2. Global Autoinjectors Market Size and Market Share By End User (2027-2033)

14. Global Autoinjectors Market, By Region, 2020-2033 (USD Million)

14.1. Global Autoinjectors Market Size and Market Share By Region (2020-2026)
14.2. Global Autoinjectors Market Size and Market Share By Region (2027-2033)
- 14.2.1. Africa
- 14.2.2. Asia - Pacific
- 14.2.3. Europe
- 14.2.4. Middle East
- 14.2.5. North America
- 14.2.6. South America

15. Company Profile

15.1. Abbie
- 15.1.1. Company details
- 15.1.2. Financial outlook
- 15.1.3. Type summary
- 15.1.4. Recent developments
15.2. Amgen
- 15.2.1. Company details
- 15.2.2. Financial outlook
- 15.2.3. Type summary
- 15.2.4. Recent developments
15.3. Bayer
- 15.3.1. Company details
- 15.3.2. Financial outlook
- 15.3.3. Type summary
- 15.3.4. Recent developments
15.4. Becton
- 15.4.1. Company details
- 15.4.2. Financial outlook
- 15.4.3. Type summary
- 15.4.4. Recent developments
15.5. Dickinson and Company
- 15.5.1. Company details
- 15.5.2. Financial outlook
- 15.5.3. Type summary
- 15.5.4. Recent developments
15.6. Eli Lilly
- 15.6.1. Company details
- 15.6.2. Financial outlook
- 15.6.3. Type summary
- 15.6.4. Recent developments
15.7. Novartis
- 15.7.1. Company details
- 15.7.2. Financial outlook
- 15.7.3. Type summary
- 15.7.4. Recent developments
15.8. Teva Pharmaceuticals
- 15.8.1. Company details
- 15.8.2. Financial outlook
- 15.8.3. Type summary
- 15.8.4. Recent developments
15.9. Ypsomed
- 15.9.1. Company details
- 15.9.2. Financial outlook
- 15.9.3. Type summary
- 15.9.4. Recent developments
15.10. Others

15 List of Abbreviations

16 Reference Links

17 Conclusion

18 Research Scope